Healthcare >> Analyst Interviews >> June 7, 2001
FRANKLIN M. BERGER is a Managing Director in the US Equity Research
Department of J. P. Morgan H & Q, having joined the firm in 1998. He is
a Senior Biotechnology Analyst and part of the Global Health Care
Research team. He received his MBA from Harvard University and both his
MA and BA degrees from Johns Hopkins University. In 2000, he became a
Founding Fellow of the Biotechnology Study Center at New York University
School of Medicine. Profile
Mr. Berger: We cover high value human therapeutic companies. To give you
an idea of the type of companies we cover, let me list
